RaQualia Pharma Inc. (TYO:4579)

RaQualia Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	22,270	24,702	8,386	14,874	25,843	24,601
Market Cap Growth	133.14%	194.57%	-43.62%	-42.44%	5.05%	17.42%
Enterprise Value	21,926	24,208	8,784	11,061	22,330	21,890
Last Close Price	856.00	1010.00	384.00	688.00	1232.00	1174.00
PE Ratio	75.35	90.48	-	-	35.74	32.58
Forward PE	-	16.89	15.07	19.50	74.48	78.27
PS Ratio	5.60	6.21	2.70	7.83	8.86	8.86
PB Ratio	3.23	3.58	1.51	2.43	4.70	5.14
P/TBV Ratio	7.04	7.81	5.03	2.44	4.72	5.18
P/FCF Ratio	-	-	99.83	-	17.84	89.79
P/OCF Ratio	-	-	46.59	-	17.46	67.22
EV/Sales Ratio	5.51	6.08	2.83	5.82	7.65	7.89
EV/EBITDA Ratio	22.60	24.96	46.72	-	22.02	25.78
EV/EBIT Ratio	45.40	50.12	-	-	25.76	30.92
EV/FCF Ratio	-52.08	-	104.57	-	15.41	79.89
Debt / Equity Ratio	0.42	0.42	0.62	0.06	0.04	0.01
Debt / EBITDA Ratio	2.99	2.99	18.35	-	0.22	0.04
Debt / FCF Ratio	-	-	41.07	-	0.15	0.14
Net Debt / Equity Ratio	-0.05	-0.05	0.02	-0.56	-0.67	-0.55
Net Debt / EBITDA Ratio	-0.35	-0.35	0.58	20.97	-3.65	-3.09
Net Debt / FCF Ratio	0.82	0.82	1.30	3.68	-2.56	-9.56
Asset Turnover	0.40	0.40	0.38	0.29	0.51	0.59
Inventory Turnover	4.37	4.37	3.98	3.16	25.67	40.13
Quick Ratio	4.06	4.06	3.40	11.22	9.18	9.66
Current Ratio	4.46	4.46	3.82	12.74	9.78	10.01
Return on Equity (ROE)	4.38%	4.38%	-8.47%	-5.56%	14.06%	17.17%
Return on Assets (ROA)	2.99%	2.99%	-1.61%	-3.21%	9.43%	9.33%
Return on Invested Capital (ROIC)	4.99%	4.93%	-5.07%	-14.93%	37.26%	29.61%
Return on Capital Employed (ROCE)	5.20%	5.20%	-2.50%	-5.20%	15.00%	14.60%
Earnings Yield	1.23%	1.10%	-5.90%	-2.17%	2.80%	3.07%
FCF Yield	-1.89%	-1.70%	1.00%	-6.21%	5.61%	1.11%
Buyback Yield / Dilution	-11.14%	-11.14%	-0.16%	-2.97%	-0.05%	-0.10%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.